tradingkey.logo
tradingkey.logo
Buscar

Myomo Inc

MYO
Añadir a la lista de seguimiento
1.030USD
0.0000.00%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
39.72MCap. mercado
PérdidaP/E TTM

Más Datos de Myomo Inc Compañía

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. The Company develops and markets the MyoPro product line, which is a myoelectric-controlled upper limb brace, or orthosis. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. MyoPro’s control technology utilizes an advanced human-machine interface based on non-invasive, patented electromyography, or EMG, control technology.

Información de Myomo Inc

Símbolo de cotizaciónMYO
Nombre de la empresaMyomo Inc
Fecha de salida a bolsaJun 12, 2017
Director ejecutivoGudonis (Paul R)
Número de empleados184
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 12
Dirección137 Portland Street
CiudadBOSTON
Bolsa de valoresNASDAQ OMX – NASDAQ Basic Amex
PaísUnited States of America
Código postal02114
Teléfono16179969058
Sitio Webhttps://myomo.com/
Símbolo de cotizaciónMYO
Fecha de salida a bolsaJun 12, 2017
Director ejecutivoGudonis (Paul R)

Ejecutivos de Myomo Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Paul R. Gudonis
Mr. Paul R. Gudonis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.36M
+7.03%
Mr. Thomas F. (Tom) Kirk, Ph.D.
Mr. Thomas F. (Tom) Kirk, Ph.D.
Lead Independent Director
Lead Independent Director
772.57K
+15.37%
Mr. David A. Henry
Mr. David A. Henry
Chief Financial Officer
Chief Financial Officer
462.35K
-4.55%
Ms. Heather C. Getz, CPA
Ms. Heather C. Getz, CPA
Independent Director
Independent Director
210.46K
+37.40%
Dr. Harry Kovelman, M.D.
Dr. Harry Kovelman, M.D.
Chief Medical Officer
Chief Medical Officer
122.01K
-14.82%
Mr. Thomas A. Crowley, Jr.
Mr. Thomas A. Crowley, Jr.
Independent Director
Independent Director
--
--
Mr. Micah J. Mitchell
Mr. Micah J. Mitchell
Chief Commercial Officer
Chief Commercial Officer
--
--
Dr. Milton M. Morris, Ph.D.
Dr. Milton M. Morris, Ph.D.
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Paul R. Gudonis
Mr. Paul R. Gudonis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.36M
+7.03%
Mr. Thomas F. (Tom) Kirk, Ph.D.
Mr. Thomas F. (Tom) Kirk, Ph.D.
Lead Independent Director
Lead Independent Director
772.57K
+15.37%
Mr. David A. Henry
Mr. David A. Henry
Chief Financial Officer
Chief Financial Officer
462.35K
-4.55%
Ms. Heather C. Getz, CPA
Ms. Heather C. Getz, CPA
Independent Director
Independent Director
210.46K
+37.40%
Dr. Harry Kovelman, M.D.
Dr. Harry Kovelman, M.D.
Chief Medical Officer
Chief Medical Officer
122.01K
-14.82%
Mr. Thomas A. Crowley, Jr.
Mr. Thomas A. Crowley, Jr.
Independent Director
Independent Director
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Myomo Inc?

Los cinco principales accionistas de Myomo Inc son: Mr. Paul R. Gudonis

¿Cuántas instituciones poseen acciones de Myomo Inc (MYO)?

A fecha de 2026Q1, 185 instituciones poseen acciones de Myomo Inc, con un valor de mercado combinado de aproximadamente 23.44M, lo que representa el 63.19% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -5843597.00.

¿Cuál es la mayor fuente de ganancias de Myomo Inc?

El 2026Q1, el segmento empresarial Direct to patient generó la ganancia más alta para Myomo Inc, ascendiendo a 7.32M y representando el 72.56% de la ganancia total.